Literature DB >> 1159096

Quantitation of immunocompetence in Hodgkin's disease.

G B Faguet.   

Abstract

In vitro cellular immunocompetence was investigated on 35 patients with Hodgkin's disease by studying their in vitro lymphocyte responsiveness to full range stimulation achieved by a spectrum of phytohemagglutinin concentrations. When compared to the normal lymphocyte profile elicited from 35 control subjects, the Hodgkin's patterns of response enabled the identification of a quantifiable lymphocyte defect present in most patients regardless of their clinical status. Increasing severity of this defect was found with progression of the disease and was most pronounced in patients with skin anergy and absolute lymphopenia. The marked abnormality observed in patients restudied after intensive therapy returned towards normal in patients achieving a long lasting, unmaintained complete remission. The data suggest the early presence of an intrinsic functional lymphocyte defect, increasing severity of which may lead to progressive immunoincompetence, reflected to vitro by imparied lymphocyte responsiveness and in vivo by skin anergy and ultimately lymphopenia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1159096      PMCID: PMC301951          DOI: 10.1172/JCI108175

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.

Authors:  J R Eltringham; H S Kaplan
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

2.  Mixed-lymphocyte reaction as assay for immunological competence of lymphocytes from patients with hodgkin's disease.

Authors:  J M Lang; F Oberling; M M Tongio; S Mayer; R Waitz
Journal:  Lancet       Date:  1972-06-10       Impact factor: 79.321

3.  Hodgkin's disease: evidence for a tumor-associated antigen.

Authors:  S E Order; M Porter; S Hellman
Journal:  N Engl J Med       Date:  1971-08-26       Impact factor: 91.245

4.  Blastogenic responses of lymphocytes from patients with untreated and treated lymphomas.

Authors:  E M Hersh; W S Irvin
Journal:  Lymphology       Date:  1969-12       Impact factor: 1.286

5.  Lymphocyte transformation changes during the clinical course of Hodgkin's disease.

Authors:  S M Jackson; J V Garrett; A W Craig
Journal:  Cancer       Date:  1970-04       Impact factor: 6.860

6.  Lymphocyte response to phytohemagglutinin in Hodgkin's disease.

Authors:  T Han; J E Sokal
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

7.  Significance of the changes in the circulating lymphoid cells in Hodgkin's disease.

Authors:  D Cowther; G H Fairley; R L Sewell
Journal:  Br Med J       Date:  1969-05-24

8.  Response to BCG vaccination and survival in advanced Hodgkin's disease.

Authors:  J E Sokal; C W Aungst
Journal:  Cancer       Date:  1969-07       Impact factor: 6.860

9.  Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Authors:  E M Hersh; J J Oppenheim
Journal:  N Engl J Med       Date:  1965-11-04       Impact factor: 91.245

10.  Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients.

Authors:  R S Brown; H A Haynes; H T Foley; H A Godwin; C W Berard; P P Carbone
Journal:  Ann Intern Med       Date:  1967-08       Impact factor: 25.391

View more
  7 in total

1.  Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.

Authors:  G B Faguet
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

2.  Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinoma.

Authors:  A M Liberati; J G Voelkel; E C Borden; A S Coates; D L Citrin; G T Bryan
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

3.  Animal model of human disease: leukemic lymphoma.

Authors:  R G Olsen; L E Mathes; L C Hebebrand; E A Hoover; W S Nichols
Journal:  Am J Pathol       Date:  1980-03       Impact factor: 4.307

4.  Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.

Authors:  E G Engleman; C J Benike; R T Hoppe; H S Kaplan; F R Berberich
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

5.  Spectrum of immunodeficiencies with Hodgkin's disease.

Authors:  J J Twomey; A H Laughter; L Rice; R Ford
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

Review 6.  Diseases associated with immunosuppression.

Authors:  E R Heise
Journal:  Environ Health Perspect       Date:  1982-02       Impact factor: 9.031

7.  Characterization and purification of an immunosuppressive factor produced by a small cell lung cancer cell line.

Authors:  T Ikeda; T Masuno; T Ogura; M Watanabe; T Shirasaka; H Hara; Y Tanio; I Kawase; S Kishimoto
Journal:  Jpn J Cancer Res       Date:  1991-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.